tiprankstipranks

Paul Schimmel Insider Profile

25 Followers
Paul Schimmel, Director at aTyr Pharma, holds 2.20M shares in aTyr Pharma (Ticker: ATYR), holds ― shares in Forte Biosciences (Ticker: FBRX), holds 307.00K shares in Alnylam Pharma (Ticker: ALNY). Most recently, Paul Schimmel Bought ― shares of aTyr Pharma on May 28, 2026 for an estimated value of $49.00K.
tipranks
Paul Schimmel

Paul Schimmel
aTyr Pharma (ATYR)
Director

Ranked #94,496 out of 108,921 Corporate Insiders

Profitable Transactions

25%
3 out of 12 Profitable Transactions

Average Return

-19.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$186M
58.74%
40.75%
0.51%
A breakdown of Paul Schimmel's holdings

Insider Roles

Repligen
(RGEN)
Director
Alnylam Pharma
(ALNY)
Director
aTyr Pharma
(ATYR)
Director
Roles that Paul Schimmel holds in companies

Most Profitable Insider Trade

Stock:
aTyr Pharma
(ATYR)
Rating:Informative Buy
Date:Jul 24, 2024 - Jul 24, 2025
Return:+187.80%
The most profitable trade made by Paul Schimmel

Paul Schimmel's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
aTyr Pharma
May 28, 2026
Director
Informative Buy
49.00K
$948.66K
FBRX
Forte Biosciences
Alnylam Pharma
Mar 14, 2018
Director
Uninformative Buy
1.37M
$75.98M
Repligen
Director
$109.53M
List of latest transactions for each holding click on a transaction to see Paul Schimmel's performance on stock

Paul Schimmel insider profile FAQ

What is the percentage of profitable transactions made by Paul Schimmel?
The percentage of profitable transactions made by Paul Schimmel is 25%.
    What is the average return per transaction made by Paul Schimmel?
    The average return per transaction made by Paul Schimmel is -19.10%.
      What stocks does Paul Schimmel hold?
      Paul Schimmel holds: ATYR, FBRX, ALNY, RGEN stocks.
        What was Paul Schimmel’s latest transaction?
        Paul Schimmel latest transaction was an Informative Buy of $49.00K.
          What was Paul Schimmel's most profitable transaction?
          Paul Schimmel’s most profitable transaction was an Informative Buy of ATYR stock on July 24, 2024. The return on the trade was 187.80%.
            What is Paul Schimmel's role in aTyr Pharma?
            Paul Schimmel's role in aTyr Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.